At the top of the CAC 40, EssilorLuxottica stock climbs nearly 3%
EssilorLuxottica is enjoying a well-oriented trading session in early afternoon, within a CAC 40 showing slight gains. The stock is extending a rebound that has been underway for several days, as its quarterly earnings approach.
A rebound that brings the price back to its 50-day moving average
The EssilorLuxottica stock rises 2.93% to €153.05, placing it among the strongest gainers in the CAC 40, which is up 0.31%. The gain reaches 7.03% over seven days, enough to bring the price to its 50-day MA (€152.81) and above its 20-day MA (€145.32), following the lows of late September. The 200-day MA remains far away at €190.08, or 19.5% above the current price, and the stock is still down 43.4% over one year. The RSI at 51 is neutral: the rebound has erased the oversold condition from late September.
Third-quarter sales, expected on October 20, following first-half growth
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
EssilorLuxottica will publish its third-quarter revenue on October 20. During the first-half 2026 results on July 28, the group reported adjusted operating profit up 15% at constant exchange rates and free cash flow of €1.07 billion. The group also cited the negative impact of currencies, with a published margin of 18.6% compared to 18.9% at constant rates.
The company also repurchased €1.2 billion in shares over twelve months, or 1.7% of its market capitalization. Over three months, the stock remains down 9%, leaving the gap with its summer levels to be made up.
SectorDispositifs médicaux et optique›Optique / lunetterie
Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext
✓ You're in! Check your spam folder.
An error occurred.
Context
Period
Period: T2 2026
Key reported figures
Revenue: 7 692 millions d'euros
Quarterly revenue: 7 692 millions d'euros
Revenue growth: 7,2 %
Risks mentioned
Effets de change défavorables : croissance publiée inférieure à celle à taux de change constants
Dépendance à quelques moteurs de croissance (myopie, wearables IA) pour soutenir le rythme
Croissance modérée d'environ 5 % des activités historiques montures et santé visuelle
Opportunities identified
Solutions de gestion de la myopie en hausse de 24 % au T2, moteur de croissance confirmé
Chiffre d'affaires des lunettes IA quasiment doublé au T2 avec Ray-Ban et Oakley
Croissance à deux chiffres en Asie-Pacifique
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
